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neous expression of CD146 was observed. When cultured in 
osteogenic media, they expressed osteonectin, osteopontin 
and procollagen I, and in micromass cultures, they produced 
collagen I. DPSCs cultured in TGF-  1/3-supplemented media 
produced extracellular matrix typical of cartilaginous tissue. 
The addition of vascular endothelial growth factor to serum-
free media resulted in the expression of endothelial markers. 
Interestingly, when cultured in neurogenic media, DPSCs ex-
hibited de novo or upregulated markers of undifferentiated 
and differentiated neural cells. Collectively, our data show 
that DPSCs are self-renewing and able to express markers of 
bone, cartilage, vascular and neural tissues, suggesting their 
multipotential capacity. Their easy accessibility makes these 
cells a suitable source of somatic stem cells for tissue engi-
neering.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 During development, stem and progenitor cells active-
ly proliferate to form tissues and organs, whereas in 
adults, they exist only as minute, often hidden, tissue-
specific subpopulations that play a role in homeostasis. 
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 Abstract 
 We isolated and expanded stem cells from dental pulp from 
extracted third molars using an innovative culture method 
consisting of low serum-containing medium supplemented 
with epidermal growth factor and platelet-derived growth 
factor BB. We evaluated the differentiation potential of these 
cells when they were growing either adherently or as micro-
mass/spheroid cultures in various media. Undifferentiated 
and differentiated cells were analyzed by flow cytometry, 
immunocytochemistry and immunoblotting. The flow cy-
tometry results showed that the dental pulp stem cells
(DPSCs) were positive for mesenchymal stromal cell markers, 
but negative for hematopoietic markers. Immunocytochem-
ical and/or immunoblotting analyses revealed the expres-
sion of numerous stem cell markers, including nanog, Sox2, 
nestin, Musashi-1 and nucleostemin, whereas they were 
negative for markers associated with differentiated neural, 
vascular and hepatic cells. Surprisingly, the cells were only 
slightly positive for   -smooth muscle actin, and a heteroge-
 Accepted after revision: August 25, 2010 
 Published online: November 11, 2010 
 Dr. Jana Karbanová 
 Tissue Engineering Laboratories, BIOTEC,  Technische Universität Dresden 
 Tatzberg 47–51, DE–01307 Dresden (Germany) 
 Tel. +49 351 463 40207, Fax +49 351 463 40244
E-Mail jana.karbanova   @   biotec.tu-dresden.de 
 © 2010 S. Karger AG, Basel
1422–6405/11/1936–0344$38.00/0 
 Accessible online at:
www.karger.com/cto 
 Characterization of Dental Pulp Stem 
Cells 
Cells Tissues Organs 2011;193:344–365 345
The dental cavity encloses a quite specific tissue type, 
dental pulp, that is well demarcated from surrounding 
tissues and, therefore, relatively easy to remove. Interest-
ingly, in young adults, the dental pulp of impacted or 
nonerupted third molar teeth still contains immature tis-
sue and, therefore, might represent a possible source of 
somatic stem cells. 
 Pioneering studies by Gronthos et al. [2000] have dem-
onstrated the existence of stem cells within dental pulp. 
Following isolation based on plastic-adherence, they 
showed that dental pulp stem cells (DPSCs) have the ca-
pacity to differentiate not only into odontoblasts, but also 
toward mesenchymal lineages (osteogenic and adipogen-
ic potentials) [Gronthos et al., 2000, 2002; Miura et al., 
2003]. Remarkably, upon the presentation of appropriate 
cues, DPSCs were observed to be able to differentiate to-
ward becoming active neurons, making them a potential 
source for cell-based therapy to cure neurodegenerative 
diseases [Arthur et al., 2008]. The neuronal potential of 
DPSCs might be related to the cranial neural crest-cell 
origin of the dental pulp [Chai et al., 2000]. Moreover, 
certain embryonic stem cell markers (such as nanog,
Oct-4, specific stage embryonic antigen-3 (SSEA-3), and 
SSEA-4) appeared to be expressed by isolated DPSCs, 
suggesting that they might have a multipotential capacity 
[Kerkis et al., 2006; Yalvac et al., 2010].
 Until now, the experimental procedures used for the 
isolation and expansion of DPSCs have relied on culture 
media containing a high concentration of serum ( 6 10%), 
which allows for better cell adhesion during the initial 
isolation of the cells [Gronthos et al., 2000; Kerkis et al., 
2006; Yalvac et al., 2010]. However, for the long-term 
culture of DPSCs, which initially represent a minute 
population, the high level of serum might lead to spon-
taneous differentiation [Tseng et al., 2007; Gou et al., 
2010] or malignant transformation [Rubio et al., 2005; 
Wang et al., 2005; Rosland et al., 2009]. Recently, we 
 demonstrated that isolated DPSCs could be efficiently 
expanded in a low serum-containing (2%) medium sup-
plemented with epidermal growth factor (EGF) and 
platelet-derived growth factor BB (PDGF-BB) over 
 Hayflick’s limit while maintaining a stable karyotype 
[Suchanek et al., 2007]. The use of growth factors (EGF 
and PDGF-BB) has been reported to stimulate prolifera-
tion of both bone marrow stromal cells and multipotent 
adult progenitor cells [Gronthos and Simmons, 1995; 
Reyes et al., 2002].
 Here, we present evidence that DPSCs cultured ex vivo 
under these conditions (that is, low level of serum) fully 
maintain their differentiation capacities toward osteo-
genic, chondrogenic, endothelial, smooth muscle and 
neural lineages. Thus, they might represent an accessible 
and reliable source of stem cells for tissue engineering 
and cell-based replacement.
 Material and Methods 
 Antibodies 
 The primary antibodies (Abs) used for immunodetection are 
listed in  table 1 , and the secondary Abs used were Cy3 TM -conju-
gated AffiniPure donkey anti-mouse IgG (H+L) and anti-goat 
Abbreviations used in this paper
-MEM -minimum essential medium 
-SMA -smooth muscle actin
Ab antibody
APC allophycocyanin
Bcrp1 breast cancer resistant protein 1
BDNF brain-derived neurotrophic factor
bFGF basic fibroblast growth factor
BMP-2 bone morphogenetic protein 2
CNTF ciliary neurotrophic factor
DAB 3,3-diaminobenzidine tetrahydrochloride
DAPI 4-6-diamidino-2-phenylindole
DMEM Dulbecco’s Modified Eagle’s Medium
DPSCs dental pulp stem cells
EGF epidermal growth factor
FCS fetal calf serum
FITC fluorescein isothiocyanate
FORSE-1 forebrain surface embryonic-1
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GDNF glial cell-derived growth factor
GFAP glial fibrillary acidic protein
Ig immunoglobulin
ITS insulin, transferrin, selenite
NF neurofilaments
NG2 neuro-glial 2
NGF nerve growth factor
Oct-4 octamer-binding transcription factor 4
PBS phosphate-buffered saline
PDGF-BB platelet-derived growth factor BB
PE phycoerythrin
PFA paraformaldehyde
RIPA radioimmunoprecipitation assay
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis
Sox-2 SRY (sex determining region Y) box 2
SSEA specific stage embryonic antigen
TGF transforming growth factor 
VEGF vascular endothelial growth factor
VEGFR2 vascular endothelial growth factor receptor 2
vWF von Willebrand factor
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IgG (H+L), Cy3 TM -conjugated goat anti-mouse IgM (Jackson Im-
munoresearch, West Grove, Pa., USA), Alexa Fluor  488-conju-
gated goat anti-mouse IgG and anti-rabbit IgG, donkey anti-goat 
IgG (Molecular Probes, Invitrogen Corp., Carlsbad, Calif., USA) 
and the anti-mouse or anti-rabbit EnVision peroxidase kit (Dako, 
Glostrup, Denmark). As controls, isotype IgG1  (MOPC-21; Sig-
ma, Darmstadt, Germany) and IgG2a  (MOPC-173; Abcam, 
Cambridge, UK) were used. For immunoblotting, horseradish 
peroxidase-conjugated AffiniPure rabbit anti-mouse IgG, goat 
anti-rabbit IgG and mouse anti-goat IgG (Jackson Immunore-
search) were used.
 Media Components 
 The composition of all media mentioned below is listed in
 table  2 . Ascorbic acid 2-phosphate,   -glycerophosphate, dexa-
methasone, ITS and ITS+1 supplements as well as proline were 
purchased from Sigma;   -MEM, high-glucose DMEM and neuro-
basal medium, B27 supplement,  L -glutamine, penicillin/strepto-
mycin and sodium pyruvate were from Gibco (Paisley, UK); fetal 
calf serum (FCS) was from PAA Laboratories (Linz, Austria), hu-
man recombinant transforming growth factor   1/3 (TGF-  1/3) 
was from R&D Systems (Minneapolis, Minn., USA); human re-
combinant basic fibroblast growth factor (bFGF), bone morpho-
genetic protein (BMP-2), EGF, PDGF and vascular endothelial 
growth factor (VEGF) were from PeproTech (London, UK). 
Antigen Clone/
antiserum
Manufacturer1 D ilution
ICC, 
IHC
WB
Stem cells
Bcrp1 (ABCG2) 5D3 Chemicon 1:100
CD184 (CXCR4) rb. as Acris 1:100 1:1,000
Musashi-1 rb. as Chemicon 1:100 1:1,000
Nanog rb. as Abcam 1:200 1:2,000
Nucleostemin g. as R&D Systems 1:10
g. as Neuromics 1:2,000
SSEA-1 MC480 DSHB 1:2
SSEA-4 MC-813-70 DSHB 1:3
Sox-2 rb. as Chemicon 1:1,000
VEGFR2 g. as R&D Systems 1:10
Mesenchymal tissue
CD29 (1-integrin) HUTS-21 BD Biosciences 1:50
CD44 DF1485 Santa Cruz 1:100
CD73 AD2 BD Biosciences 1:50
CD90 F-15-42-1 Acris 1:100
CD146 N1238 Novocastra 1:50 1:500
P1H12 BD Biosciences 1:50
CD166 3A6 BD Biosciences 1:50
STRO-1 STRO-1 DSHB 1:4
Vimentin V9 Sigma 1:40
Hematopoietic cells
CD34 581 BD Biosciences 1:50
CD45 HI30 BD Biosciences 1:50
CD133 AC133 Miltenyi Biotec 1:20
Bone
Osteonectin 15G12 Novocastra 1:40
Osteopontin MPIIIB101 DSHB 1:4
Procollagen I M-38 DSHB 1:4
Endothelium
CD31 (PECAM-1) JC/70A Dako 1:20
CD34 Class II QBEnd10 Dako 1:20
CD105 (endoglin) P3D1 DSHB 1:4
CD106 (VCAM-1) 1.4C3 Dako 1:20
vWF rb. as Dako 1:300
Antigen Clone/
antiserum
Manufacturer1 D ilution
ICC, 
IHC
WB
Muscle tissue
-actinin EA-53 Sigma 1:200
-SMA 1A4 Sigma 1:400 1:2,000
Desmin DE-R-33 Sigma 1:200
Skeletal myosin MY-32 Sigma 1:400
Neural tissue
A2B5 A2B5-105 Chemicon 1:100
-III tubulin TU-20 Exbio 1:50
FORSE-1 FORSE-1 DSHB 1:4
GFAP rb. as Dako 1:400
Nestin 10C2 Chemicon 1:200 1:2,000
NG2 rb. as Chemicon 1:200
O4 81 Chemicon 1:100
PanNF DA2, FNPT
(NF-M)
Rmd020,11
Zymed pre-
diluted
RC-2 RC2 DSHB 1:4
S-100 rb. as Dako 1:300
Others
Actin AC-40 Sigma 1:5,000
-Fetoprotein rb. as Dako 1:200
-Tubulin YOL-1/34 Serotec 1:500
Melanosome HMB45 Dako 1:40
Pan Cytokeratin KL-1 Immunotech pre-
diluted
as  = Antiserum; ICC = immunocytochemistry; IHC = immunohisto-
chemistry; WB = immunoblotting, rb = rabbit; g = goat.
1 Abcam (Cambridge, UK), Acris Antibodies GmbH (Herford, Ger-
many), BD Biosciences (Heidelberg, Germany), Dako (Glostrup, Den-
mark), Developmental Studies Hybridoma Bank (DSHB, Iowa City, Iowa, 
USA; N01-HD-6-2915, NICHD), Exbio (Prague, Czech Republic), Chemi-
con (Temecula, Calif., USA), Immunotech (Marseille, France), Miltenyi 
Biotec (Bergisch Gladbach, Germany), Neuromics (Northfield, Minn., 
USA), Novocastra Laboratories (Newcastle, UK), R&D systems (Minne-
apolis, Minn., USA), Santa Cruz Biotechnology Inc. (Santa Cruz, Calif., 
USA), Serotec (Oxford, UK), Sigma (Darmstadt, Germany), Zymed Labo-
ratories Inc. (San Francisco, Calif., USA).
Table 1.  Primary antibodies used for immunodetection
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 Cell Isolation and Culture  
 DPSCs were isolated from impacted third molars of healthy 
young donors (n = 9) aged 17–23 years undergoing tooth extrac-
tion for orthodontic reasons [Suchanek et al., 2007]. All tissue 
materials were acquired under informed consent and processed 
according to guidelines approved by the Ethical Committee of the 
Faculty Hospital in Hradec Králové. DPSCs were isolated as de-
scribed previously [Gronthos et al., 2000; Suchanek et al., 2007]. 
Briefly, removed pulp tissue was digested with collagenase (0.2 
mg/ml; Sevapharma, Prague, Czech Republic) and dispase (2 mg/
ml; Gibco) for 70 min at 37   °   C, mechanically dissociated and fil-
tered through a 70-  m cell strainer (BD Falcon; BD Biosciences, 
Heidelberg, Germany). Pulp cell suspensions were generally cul-
tured in a basic expansion medium ( table 2 ). The medium was 
changed every 2 or 3 days. The first passage was done when single 
colonies appeared (that is, after 5–10 days), and afterwards, cells 
were trypsinized upon reaching 70% confluence. Cells were split 
1: 3. In some experiments, freshly isolated cells were cultured in a 
standard medium ( table 2 ). 
 DPSC Differentiation 
 Dental pulp-derived cells were initially cultured in basic ex-
pansion medium for at least one passage prior to differentiation. 
The following media and conditions were used for the ex vivo dif-
ferentiation of DPSCs.
Table 2. L ist and composition of cultivation media
Name Media Serum (FCS) Additives
Basic -MEM 0.2 mM ascorbic acid 2-phosphate
50 nM dexamethasone
2 mM L-glutamine
100 U/ml penicillin; 100 g/ml streptomycin
Basic expansion basic 2% 10 ng/ml EGF
10 ng/ml PDGF-BB
Standard -MEM 10% 0.2 mM ascorbic acid 2-phosphate
2 mM L-glutamine
100 U/ml penicillin; 100 g/ml streptomycin
Osteogenic -MEM 10% 0.2 mM ascorbic acid 2-phosphate
2 mM L-glutamine
100 U/ml penicillin; 100 g/ml streptomycin
10 mM -glycerophosphate
0.1 M dexamethasone
Chondrogenic A basic 50 ng/ml TGF-1
Chondrogenic B high glucose
DMEM
0.2 mM ascorbic acid 2-phosphate
0.1 M dexamethasone
1% ITS+1 supplement
100 U/ml penicillin; 100 g/ml streptomycin
40 g/ml proline
100 g/ml sodium pyruvate
10 ng/ml TGF-3
Endothelial basic [10%] 1% ITS supplement
20 ng/ml VEGF
Smooth muscle cell/myofibroblast basic 10 ng/ml TGF-1
Neurogenic neurobasal 2% B27 Supplement
2 mM L-glutamine
100 U/ml penicillin; 100 g/ml streptomycin
10 ng/ml bFGF
20 ng/ml EGF
[50 ng/ml BMP-2]
Neurogenic expansion neurogenic 1% [50 ng/ml BMP-2]
S quare brackets show optional components.
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 Osteodifferentiation 
 DPSCs growing as either a confluent cell monolayer or a mi-
cromass high-density cell culture, which was generated by spon-
taneous cell aggregation (10 6 cells) in round-bottomed 4-ml cul-
ture tubes, were differentiated using osteogenic medium ( table 2 ) 
[Pittenger et al., 1999]. The medium was exchanged every 2–3 
days.
 Chondrodifferentiation 
 DPSCs growing as a micromass culture (10 6 cells) were differ-
entiated using two alternative media, A or B ( table 2 ) [Mackay et 
al., 1998]. Media were exchanged every 2–3 days.
 Endothelial Differentiation 
 DPSCs were plated at a density of 2  ! 10 4 /cm 2 on polyorni-
thine/fibronectin-coated coverslips and cultured in serum-free 
endothelial medium ( table 2 ). The medium was exchanged every 
2–3 days. In some experiments, after 10 days, 10% FCS was added 
to the medium and cells were further expanded for 10–21 days.
 Smooth Muscle Cell/Myofibroblast Differentiation 
 DPSCs were cultured in smooth muscle cell/myofibroblast 
differentiation medium ( table 2 ). Media were exchanged every 2 
days.
 Neural Differentiation 
 DPSCs were cultured as a cell monolayer in neurogenic expan-
sion medium ( table 2 ) for at least 3 passages. After that, cells were 
further cultured as a monolayer either in neurogenic ( table 2 ) or 
neurogenic expansion medium supplemented with (or without) 
BMP-2 (PeproTech) or as spheroids in nontreated T-flasks 
(Sarstedt, Nümbrecht, Germany). Media were exchanged every 
2–3 days.
 Cytochemistry 
 Cells growing on polyornithine/fibronectin-coated coverslips 
were washed 3 times in PBS and then fixed with 4% paraformal-
dehyde (PFA) in PBS at 4   °   C for 10 min, methanol/acetone at 
–20   °   C for 5 min or using a combination of both protocols. After 
thorough washing with PBS, cells were permeabilized with 0.1% 
Triton X-100 for 10 min at room temperature (only for the PFA 
fixation protocol), blocked in PBS containing either 5% normal 
goat (Sigma) or donkey serum (Jackson Immunoresearch) and 
then incubated with a given primary Ab ( table 1 ) at 4  °  C overnight. 
As a negative control, the primary Ab was omitted. After washing, 
cells were incubated with the appropriate fluorochrome-conju-
gated species-specific secondary Ab at room temperature for 45 
min. Nuclei were counterstained with 4’-6-diamidino-2-phenyl-
indole (DAPI; Sigma). Coverslips were mounted in polyvinyl al-
cohol/glycerol containing the antifading agent 1,4-diazobicyclo-
[2.2.2]-octane. Samples were examined using a BX51 Olympus 
microscope equipped with an Olympus DP71 digital camera, and 
the images were prepared using Adobe  Photoshop and Illustra-
tor software.
 Cell Surface Immunofluorescence 
 Cell surface labeling was performed as described previously 
[Corbeil et al., 2000]. Briefly, cells grown on coverslips were 
washed twice with PBS followed by ice-cold Ca/Mg-PBS (PBS 
containing 1 m M CaCl 2 , 0.5 m M MgCl 2 ) and then incubated with 
primary Abs ( table 1 ) diluted in immunofluorescence buffer (Ca/
Mg-PBS containing 0.2% gelatin) for 30 min at 4  °  C. Unbound Abs 
were removed by 5 washes with ice-cold immunofluorescence 
buffer. Fixative, 4% PFA in PBS, was added to the cells on ice, and 
the coverslips were placed at room temperature for 15 min. The 
fixative was removed by 3 washes with Ca/Mg-PBS, and the re-
sidual PFA was quenched with 50 m M NH 4 Cl for 10 min. The cells 
were then incubated with Cy3 TM -conjugated anti-mouse second-
ary Ab for 30 min at room temperature. After washing in PBS, 
nuclei were counterstained with DAPI, and coverslips were rinsed 
sequentially with PBS and distilled water and mounted in Mowi-
ol (Merck, Darmstadt, Germany). 
 Histochemistry 
 Dental pulp removed from the dental cavity or DPSCs grow-
ing either as micromass cultures or multilayered nodules  were 
fixed with 10% formalin and embedded in paraffin. Serial sec-
tions (5–6   m) were cut, mounted on glass slides pretreated with 
chrome alum-gelatin, and dried at room temperature overnight. 
Paraffin-embedded sections were deparaffinized by xylol treat-
ment, hydrated with decreasing concentrations of ethanol (96, 80 
and 70%), and then rinsed twice with distilled water. 
 Spheroid cultures were fixed in 4% PFA in PBS for 30 min, 
cryoprotected by treatment in 20% sucrose in PBS for 2 h, embed-
ded in TissueTek  OCT TM compound (Sakura Finetek, Staufen, 
Germany), processed for cryosections, and mounted on slides 
pretreated with 3-aminopropyltriethoxysilane (Sigma). Cryosec-
tions were permeabilized with 0.1% Triton X-100 for 10 min at 
room temperature. For peroxidase immunodetection, endoge-
nous peroxidase activity was quenched, and samples were further 
processed as described below. For fluorescent immunodetection, 
permeabilized sections were blocked in PBS containing 5% nor-
mal goat serum (Sigma), immunolabeled and mounted as de-
scribed (see Cytochemistry section).
 For antigen retrieval, deparaffinized sections were exposed to 
microwaves (700 W) in sodium citrate solution (pH = 6.0) 2 times, 
for 5 min each. After extensive washing with distilled water, en-
dogenous peroxidase activity was quenched by incubating sam-
ples in 3% H 2 O 2 (3  ! 10 min). Sections were then incubated in 
blocking buffer (5% normal goat serum in PBS) for 20 min and 
exposed to primary Ab ( table 1 ) diluted in Antibody Diluent with 
Background Reducing Components (Dako) at 4  °  C overnight. As 
negative controls, matching mouse isotype controls were used or 
the primary Ab was omitted. After washing with PBS, sections 
were incubated with reagents from either an anti-mouse or anti-
rabbit EnVision peroxidase kit according to the manufacturer’s 
protocol. Color reactions were performed using the chromogen 
DAB (3,3  -diaminobenzidine tetrahydrochloride, 2   g/ml; Fluka, 
Darmstadt, Germany). After washing with distilled water, DAB 
precipitate was intensified with 3% CuSO 4 solution for 5 min. Sec-
tions were then counterstained with either Mayer’s hematoxylin 
(Merck) or light green (BDH Stains, Poole, UK), dehydrated and 
mounted in DPX (Fluka). 
 In osteoids, collagen I was detected using blue trichrome 
staining modified according either to Masson or Ladewig. Cal-
cium phosphate was detected using von Kossa staining. Acid mu-
cins were visualized by Alcian blue staining (1% Alcian blue solu-
tion in 3% acetic acid, 30 min). Tissues were then dehydrated and 
mounted in DPX (Fluka).
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 Flow Cytometry 
 DPSCs were harvested by trypsin/EDTA treatment for 5 min 
at 37   °   C. After inactivation of trypsin and centrifugation (5 min 
at 300  g ), 100   l of the cell suspensions (10 5 cells) were incubated 
for 30 min at 4   °   C with the following fluorochrome-conjugated 
Abs: CD29-phycoerythrin (PE; HUTS-21), CD34-allophycocya-
nin (APC; clone 581), CD44-fluorescein isothiocyanate (FITC; 
G44-26), CD45-PE (HI30), CD73-PE (AD2), CD90-FITC (5E10), 
CD146-PE (P1H12), CD166-PE (3A6; all from BD Biosciences); 
CD29-PE (MEM-101A; Invitrogen); CD133-APC (AC133-1) and 
CD146-APC (541-10B2; both from Miltenyi Biotec, Bergisch 
Gladbach, Germany). After washing with PBS, 10,000 events were 
acquired on an LSRII flow cytometer (BD Biosciences). Instru-
ment settings and gating strategies were established using isotype 
controls, and data were analyzed using FlowJo software (TreeStar, 
Ashland, Oreg., USA). 
 Protein Extraction and Immunoblotting 
 Cells were washed and scraped in ice-cold PBS, followed by 
their solubilization in RIPA buffer (1% NP-40, 0.5% deoxycholate, 
0.1% sodium dodecylsulfate, 150 m M NaCl, 50 m M Tris-HCl, pH 
8.0) in the presence of 1 m M phenylmethylsulfonyl fluoride
and complete protease inhibitors (Roche, Basel, Switzerland) for 
30 min at 4  °  C. After centrifugation (10 min, 16,000  g ), the protein 
concentration in supernatant was determined using a BSA pro-
tein assay (Pierce Biotechnology, Rockford, Ill., USA). Proteins 
from each sample (25   g) were resuspended in Laemmli sample 
buffer, heated for 5 min at 95   °   C, separated by SDS-PAGE (7.5%) 
and transferred to a polyvinylidene fluoride membrane (pore size 
0.45   m; Millipore, Schwalbach, Germany), as previously de-
scribed [Corbeil et al., 2001]. Membranes were incubated at 4   °   C 
overnight in blocking buffer (PBS containing 5% low fat milk 
powder and 0.3% Tween 20) and then probed with a given pri-
mary Ab ( table 1 ) for 1 h at room temperature. Antigen-Ab com-
plexes were detected using the appropriate horseradish peroxi-
dase-conjugated secondary Ab and visualized with enhanced 
chemiluminescence-developing reagents (ECL system; Amer-
sham Corp., Arlington Heights, Ill., USA). Membranes were gen-
erally exposed for 1–10 min to autoradiographic films (Hyperfilm 
ECL; Amersham-Pharmacia).
 RT-PCR Analysis 
 Total RNA was prepared from undifferentiated as well as os-
teo- and chondrodifferentiated DPSCs using an RNeasy Mini Kit 
with column DNAase treatment according to the manufacturer’s 
instructions (Qiagen GmbH, Hilden, Germany). cDNA was syn-
thesized using a High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, Calif., USA) from 1   g of total 
RNA in a 20-  l reaction volume, followed by PCR using Platinum 
Taq DNA polymerase (Invitrogen) for gene amplification. PCR 
was performed using a Mastercycler ep gradient S (Eppendorf, 
Hamburg, Germany) for 35 cycles consisting of 45 s denaturation, 
94  °  C; 45 s annealing, 62  °  C; 90 s extension, 72  °  C; with initial de-
naturation for 5 min, 94  °  C and final extension for 10 min, 72  °  C. 
The primer pairs used are listed in  table 3 . After PCR, 5-  l ali-
quots of the products were subjected to 1.7% agarose gel electro-
phoresis, stained with ethidium bromide and visualized by UV 
illumination. 
Table 3.  List of primers used for RT-PCR analysis
Gene Accession
number
Forward primer (5→3)
Reverse primer (5→3)
Product
size, bp
Annealing
temperature, ° C
Oct-41 NM_002701 CGACCATCTGCCGCTTTGAG 573 64
CCCCCTGTCCCCCATTCCTA
Nanog NM_024865 GGCAAACAACCCACTTCTGC 428 62
CAGGACTGGATGTTCTGGGTCT
Sox-2 NM_003106 CCGTTCATCGACGAGGCTAAG 425 62
TGCTGCGAGTAGGACATGCTG
Bone sialoprotein NM_004967 CACCACAGAGACCGGAAGGC 331 62
TCCCAGGCTGGAGCTTCACT
Osteocalcin NM_199173 ACACCATGAGAGCCCTCACA 322 62
AGCAGAGCGACACCCTAGAC
Aggrecan NM_001135 ACTGCTGCAGACCAGGAGGT 410 62
TTGTAGGTGGTGGCTGTGCC
Collagen II 
(COL2A1)
NM_001844 GCTATGGAGATGACAATCTGGC 344 62
CTCGGGCCCTCCTATGTCCA
GAPDH2 NM_002046 CGGGAAGCTTGTCATCAATGG 358 62
GGCAGTGATGGCATGGACTG
1  Primers designed according to McLaughlin et al. [2006]. 2 Primers designed according to Kudo et al. [1998].
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 Statistical Analysis 
 Statistical analysis was performed using Wilcoxon signed-
rank test. A probability of p  ̂  0.05 was considered as statisti-
cally significant.
 Results 
 Characterization of Cultured DPSCs 
 DPSCs were isolated from dissociated dental pulp on 
the basis of their adhesion to a plastic substratum as pre-
viously described [Gronthos et al., 2000]. Upon being cul-
tured in low serum-containing medium (2% FCS) sup-
plemented with EGF and PDGF-BB, hereafter referred to 
as basic expansion medium, the fresh pulp cell suspen-
sions contained both single cells and multicellular struc-
tures ( fig.  1 a). During the first 48–72 h, cells adhered 
( fig. 1 b, c) but they proliferated poorly (data not shown). 
Colonies were observed after 5–7 days ( fig. 1 d). Cells gen-
erally exhibited a fibroblast-like morphology. Interest-
ingly, they started to proliferate and generated a mono-
layer upon the first passage ( fig. 1 e). Without serum in the 
culture medium, the initial cell adhesion was altered, and 
similarly no expansion was observed in the absence of 
EGF and PDGF-BB (data not shown).
 Next, we evaluated the antigenic profile of undifferen-
tiated DPSCs by 3 distinct, but complementary, methods, 
namely immunocytochemistry ( fig.  1 ,  2 ,  6–8 ;  table  4 ), 
flow cytometry ( fig. 2 ;  table 5 ,  6 ) and immunoblotting 
( fig. 3 a–c). The data are compiled in  table 4 . DPSCs dis-
played a high expression of markers associated with mes-
enchymal stromal cells, such as STRO-1, vimentin, CD29, 
CD44, CD73, CD90 and CD166 ( fig. 1 f, g,  2 a). Their ex-
pression appeared independent of the number of passag-
es (up to 20) and donors ( table 5 ). In contrast, the expres-
sion of CD146 varied in the intensity ( fig. 2 a), and in the 
number of positive cells among donors ranging between 
0 and 38% ( tables 5 ,  6 ). DPSCs expressed numerous neu-
ral-associated stem cell markers such as nestin, nucle-
ostemin, Musashi-1 and chondroitin sulfate proteogly-
can NG2 (neuro-glial 2;  fig. 1 h–k). Other markers associ-
ated with stem cells, for example, chemokine receptor 
CXCR4 and VEGF receptor 2 (VEGFR2), were expressed 
as well ( fig. 1 l, m). Bcrp1 was weakly and heterogeneous-
ly expressed ( fig. 8 d, inset). Less than 1% of these cells 
were positive for forebrain surface embryonic-1 (FORSE-
1;  fig. 8 c, inset), SSEA-1 and SSEA-4 ( fig. 1 n, o). However, 
they strongly expressed other markers associated with 
embryonic stem cells, including nanog and Sox-2 ( fig. 1 p, 
q). Finally, DPSCs were negative for the hematopoietic 
markers CD34, CD45 and CD133 ( fig. 2 b;  table 5 ) or neg-
ative/weakly positive for markers associated with differ-
entiated or lineage-committed cells, such as   -smooth 
muscle actin (  -SMA,  fig. 4 a), glial fibrillary acidic pro-
tein (GFAP), A2B5, O4, PanNF (neurofilaments),   -III 
tubulin ( fig. 8 h, e, i–k, insets), osteopontin, osteonectin, 
procollagen I ( fig.  6 a–c, insets), von Willebrand factor, 
CD31, CD105 and CD106 ( fig. 7 a, c–f, insets;  table 4 ). The 
immunoblotting experiments and RT-PCR analyses con-
firmed that both the protein and/or transcripts of the ma-
jor markers associated with neural and embryonic stem 
cells including Oct-4, nanog and Sox-2 were expressed 
( fig. 3 a–c, lane 1; 3d, lanes 1–3).
 Compared to DPSCs that are isolated and expanded in 
culture media containing a higher concentration of se-
rum (10–20%) as used in earlier studies [Gronthos et al., 
2000; Kerkis et al., 2006; Yalvac et al., 2010], which may 
allow for better cell adhesion and, hence, the isolation of 
a larger cell population, the expression of early stem cell 
markers by cells isolated in low serum-containing media 
indicated that the use of a lower serum concentration is 
not disadvantageous. Nevertheless, when 10% instead of 
2% FCS was used, we observed that the expression level 
of 3 of the markers examined appeared to be altered 
( fig. 3 a, b, lane 1 vs. 2). Nestin and Sox-2 were decreased, 
whereas Musashi-1 was increased in cells derived from 
culture containing high versus low amounts of serum 
( fig. 3 a, b). The expression of nucleostemin, NG2, nanog 
and CXCR4 remained constant ( fig. 3 a–c). RT-PCR con-
firmed these trends ( fig. 3 d). More strikingly, the expres-
sion level of CD146, which has shown great variability in 
our culture system (see above), and   -SMA were signifi-
cantly lower in cells isolated and cultured in the low se-
rum-containing media compared to high serum-content 
media ( fig. 4 b, lane 1 (BE) vs. 7 (S)). Interestingly, shifting 
the culture media of DPSCs already isolated and cultured 
in medium containing low amounts of serum (2%) to one 
containing high amounts of serum (10%) did not cause a 
major upregulation of these markers (by comparison to 
those isolated and cultured in high serum content), even 
after 5 passages ( fig. 4 a, b, BE]S), suggesting that serum 
per se has a limited effect on their activation.
 To gain more insight into the potential origin of
DPSCs in situ, we performed immunohistochemistry
on paraffin-embedded sections of dental pulp from im-
pacted third molars ( fig. 5 ). Interestingly, we could dis-
tinguish at least 4 possible and/or alternative sources
of DPSCs according to the localization of proteins that 
are expressed ex vivo ( fig.  1–4 ). First, perivacular cells 
had the molecular signature   -SMA, CD146, Musashi-1, 
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 Fig. 1. Immunocytochemistry of cultured DPSCs. Dental pulp-
derived, undifferentiated DPSCs cultured in basic expansion me-
dium were observed by phase contrast microscopy after 5 ( a ) and 
72 h ( b ,  c ) and 7 days ( d ) in culture or 48 h after their first passage 
( e ). The expression of several antigenic markers, as indicated, was 
monitored from the 3rd to the 6th passage by indirect immuno-
fluorescence microscopy ( f–v ). As a negative control (Ctrl), Alexa 
Fluor 488-conjugated anti-mouse or anti-rabbit IgG and Cy3-
conjugated anti-mouse IgM secondary Abs were used alone ( w–y , 
respectively). Nuclei were visualized with DAPI (blue;  f–y ). Rep-
resentative examples based on the evaluation of at least 4 donors 
are shown. Scale bars = 50   m. 
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 Fig. 2. Flow cytometry and cell 
surface immunofluorescence of 
cultured DPSCs. Undifferenti-
ated DPSCs cultured in basic ex-
pansion medium were either 
trypsinized and analyzed by 
flow cytometry, or intact cells 
were directly labeled at 4   °   C us-
ing a panel of mesenchymal ( a )
or hematopoietic ( b ) cell surface 
markers, as indicated. For the 
flow-cytometric analysis, the 
antigen expression (open area) 
and the appropriate isotype-
matching control (grey filled 
area) are depicted in the upper 
panels. The corresponding im-
munofluorescence labeling is 
presented in the lower panels. A 
representative experiment is 
shown (n = 4). Scale bars = 50 
  m. 
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 nestin and NG2 ( fig. 5 a–e, black arrowhead). The perivas-
cular niche has been proposed as the potential source of 
DPSCs [Shi and Gronthos, 2003]. Second, the intranerve 
cells expressed   -SMA, Musashi-1, nestin and NG2 
( fig.  5 a–e, blue arrowhead). The nerves were identified 
with Schwann cell-associated protein S-100 ( fig.  5 f). 
Third, pulpocytes found in connective tissue were posi-
tive for   -SMA, Musashi-1, nestin and NG2 ( fig.  5 a–e, 
white arrowhead). Fourth, perineural cells surrounding 
nerve fibers were positive for Musashi-1, nestin and NG2 
( fig.  5 a–e, yellow arrowhead), whereas they lacked   -
SMA and CD146 expression ( fig. 5 a, b). Taken together, 
these data showed that dental cells expressing a certain 
combination of specific markers are located in different 
areas within dental pulp, supporting the idea of multiple 
sources or niches of distinct multipotent DPSCs.
 Differentiation Capacity of Cultured DPSCs 
 Our phenotypic characterization described above sug-
gests that dental pulp-derived cells cultured in low se-
rum-containing media maintain a multipotential capac-
ity, particularly with regard to the expression of early 
stem cell markers. Consequently, we investigated this is-
sue by differentiating them into various cell lineages.
 Osteogenic and Chondrogenic Differentiation 
 To evaluate mesenchymal properties of DPSCs, we 
tested their ability to generate either osteoblasts or chon-
droblasts using appropriate media and culture conditions 
(for details see the Materials and Methods section). In 
cells growing as a monolayer for 2 weeks in osteogenic 
medium, we detected bone-related proteins, such as pro-
collagen I, osteonectin and osteopontin ( fig.  6 a–c). In 
multilayer nodules that were generated after 3–4 weeks 
( fig. 6 d), collagen I fibers and deposits of calcium phos-
phate were observed ( fig. 6 e, f). Similarly, in micromass 
cultures, both osteonectin and collagen I were detected 
( fig. 6 g, i). In both culture conditions after 6 weeks, we 
detected an upregulation of osteocalcin and bone sialo-
protein transcripts ( fig. 6 m).
d
a
b
c
 Fig. 3. Expression of neural, embryonic stem cell and other 
markers by DPSCs isolated and cultured in different media. The 
expression of neural and embryonic stem cell ( a ,  b , respectively) 
and other ( c ) marker proteins by DPSCs, initially isolated either 
in basic expansion medium (BE, lane 1) or standard (S, lane 2) 
medium, was detected by immunoblotting using specific Abs. 
Up- or downregulation of these markers was monitored when 
DPSCs isolated in basic expansion medium were further cul-
tured in neurogenic expansion medium (NE, lane 3).   -Tubulin 
was used as a loading control. The position of prestained appar-
ent molecular mass markers is indicated on the left. A represen-
tative experiment is shown (n = 4). Expression of Oct-4, nanog 
and Sox-2 transcripts by DPSCs isolated and cultured in basic 
expansion or standard medium was detected by RT-PCR ( d ). 
GAPDH was used as an internal control. C = Negative control, 
that is without cDNA template; M = 100 bp DNA ladder. Each 
lane (1–6) represents an independent donor; cells were approxi-
mately at the 9th passage.  
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 Fig. 4. Differential expression of CD146 and   -SMA in DPSCs 
isolated and cultured in different media. The expression of CD146 
and/or   -SMA was monitored using immunofluorescence ( a ,  c ) 
and immunoblotting ( b ) in DPSCs isolated and cultured in basic 
expansion medium (BE) or standard medium (S) or cells shifted 
from basic expansion either to standard medium and expanded 
for 5 passages ( a ,  b ) or to basic medium (B) supplemented or not 
with TGF-  1 and differentiated for five days ( c ). As a negative 
control (Ctrl), a Cy3 TM -conjugated anti-mouse IgG secondary Ab 
was used alone ( a ,  c ). Nuclei were visualized with DAPI. In  b ,   -
tubulin was used as a loading control. The position of prestained 
apparent molecular mass markers is indicated on the left. Note 
that change of culture conditions increased CD146 and   -SMA 
levels only slightly ( b ), and the immunoreactivity remained pres-
ent only in few cells even after the 5th passage, which in the case 
of CD146 was represented mainly by weak dot-like positive signal 
( a , middle column, white arrows). A representative experiment is 
shown (n = 3). Scale bars = 50   m. 
Antigen BE I nductive culture
O E NE
Stem cells
Bcrp1 (ABCG2) +/–* ++
CD184 (CXCR4) + +
Musashi-1 + ++
Nanog ++ +
Nucleostemin + +
SSEA-1 (+/–)* (+)
SSEA-4 (+/–)*
Sox-2 + ++
VEGFR2 (+/–) (+) (+)
Mesenchymal tissue
CD29 (1-integrin) ++ ++
CD44 ++
CD73 ++
CD90 ++
CD146 (+/–)*
CD166 ++
STRO-1 ++ +
Vimentin ++ ++ ++
Hematopoietic cells
CD34 –
CD45 –
CD133 (prominin-1) –
Bone
Osteonectin +/– +
Osteopontin +/– +
Procollagen I +/– ++
Endothelium
CD31 (PECAM-1) – (+)
CD34 Class II – (+)
CD105 (endoglin) +/– (+)
CD106 (VCAM-1) – (+)
vWF – (++)
Table 4.  Summary of the antigenic profile of DPSCs before and upon their differentiation
Antigen BE I nductive culture
O E NE
Muscle tissue
-Actinin1 –
-SMA (+/–)
Desmin –
Skeletal myosin1 –
Neural tissue
A2B5 +/– ++
-III tubulin – (+)
FORSE-1 (+/–) (+)
GFAP – +
Nestin + (+/–) + ++
NG2 + +
O4 (+/–) +
PanNF (+/–) (++)
RC-2 – ++
S-100 – +/–
Others
-Fetoprotein –
Melanosome –
Pan Cytokeratin (+/–)
Cel ls were grown in basic expansion (BE), osteogenic (O), en-
dothelial (E) or neurogenic expansion (NE) media. Signal inten-
sity: ++ = Strong; + = medium; +/– = weak; – = no signal. Paren-
theses show heterogeneous expression (subpopulation of cells). 
Asterisks show variability among donors.
1 Data were acquired by immunocytochemistry.
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 In 3-week-old chondrogenic micromass bodies grow-
ing in 2 distinct chondrogenic differentiation media, we 
also observed acid mucin deposits characteristic of carti-
laginous matrix ( fig. 6 j, l). Moreover, we could detect an 
upregulation of collagen II and proteoglycan aggrecan 
transcripts ( fig. 6 n). Collectively, these data suggest that 
ex vivo expanded DPSCs generate osteoblast- and chon-
droblast-like cells.
 Endothelial Induction 
 To evaluate whether DPSCs can be induced to an en-
dothelial lineage, we cultured them in endothelial differ-
entiation medium. Successful endothelial induction was 
achieved only under a proper cell plating concentration 
(about 2  ! 10 4 /cm 2 ). Thus, after 7 days, we could detect 
an upregulation of von Willebrand factor, but not when 
the cells were seeded at a higher cell density (about 3  ! 
10 4 /cm 2 ;  fig. 7 a, b, respectively). Under low-density con-
dition, approximately 10% of cells displayed an upregula-
tion of the endothelial markers CD31, CD34 class II, 
CD105 and CD106 ( fig. 7 c–f; see corresponding inset for 
noninduced con ditions). Furthermore, they maintained 
VEGFR2 and nestin expression ( fig. 7 g, h). Because cell 
proliferation was impaired and a downregulation of cer-
tain markers (CD31, CD34 class II and CD105) was ob-
served during the second week of culture (data not 
shown), we added 10% serum after 1 week, which could 
restore both cell proliferation and the endothelial-like 
phenotype ( fig. 7 l–p).
 Smooth Muscle Cell/Myofibroblast Differentiation 
 In addition to all other cell lineages described, we 
demonstrated that DPSCs expanded in medium contain-
ing low amounts of serum have the capacity to differenti-
ate into smooth muscle cells/myofibroblasts. The addi-
tion of TGF-  1 [Kleber et al., 2005] to basic medium re-
sulted in the upregulation of   -SMA expression with a 
fibrillary appearance ( fig. 4 c, left panels), which was not 
the case for basic medium alone ( fig. 4 c, right panels). 
Table 5.  The expression of various cell surface markers of undif-
ferentiated DPSCs analyzed by flow cytometry
Antigen Passage No. 5–10, % Passage No. 15–20, % p value
CD29 98.6 (93.0; 98.7) 97.6 (78.7; 98.7) 0.154
CD34 0.1 (0.068; 0.24) 0.26 (0.24; 0.72) 0.343
CD44 99.8 (99.6; 99.9) 99.5 (98.8; 99.7) 0.466
CD45 0.28 (0.17; 0.44) 0.3 (0.17; 0.41) 0.813
CD73 99.7 (99.6; 99.8) 99.6 (99.3; 99.7) 0.057
CD90 99.7 (99.6; 99.8) 99.49 (99.1; 99.6) 0.057
CD133 0.094 (0.04; 0.27) 0.19 (0.15; 0.22) 0.262
CD146 14.8 (4.23; 23) 10.1 (4.67; 24) 0.343
CD166 99.8 (99.7; 99.8) 99.6 (98.2; 99.8) 0.072
D ata are given as medians with lower and upper quartiles (in 
parentheses) of percentage of positive cells acquired from 10,000 
events of 9 independent donors that were measured in two differ-
ent culture periods as indicated. Note that there is no statistical 
difference of marker expression between evaluated time periods 
as confirmed by Wilcoxon signed-rank test (p ≤ 0.05).
Table 6. The expression of CD146 on undifferentiated DPSCs an-
alyzed by flow cytometry 
Donor C D146 immunoreactivity, %
Passag e No. 5–10 Passage No. 15–20
1 33.8 31.6
2 14.8 10.1
3 23 24
4 0.91 0.2
5 0 1.65
6 17.8 8.89
7 12.8 10.3
8 35.5 37.9
9 4.23 4.67
Data are the percentage of CD146-positive cells acquired from 
10,000 events of 9 independent donors that were measured during 
two different culture periods as indicated.
 Fig. 5. Potential localizations of DPSCs within the dental pulp 
from impacted third molars. Human dental pulp was processed 
for immunoperoxidase histochemistry using a panel of Abs, as 
indicated ( a–f ). As negative controls (Ctrl), either mouse isotype 
IgG2a (MOPC-173;  g ) or IgG1 (MOPC-21;  h ) controls were used, 
or the primary Ab was omitted ( i ). Sections were counterstained 
either with hematoxylin ( a–c ,  e–i ) or light green ( d ). Dotted and 
dashed lines indicate arteries (a) and nerves, respectively. Con-
nective tissue (CT) and veins (v) are indicated. Colored arrow-
heads show the immunoreactivity of a given protein, as indicated 
in the respective panel, in a particular cell type. Arrowheads: 
black =perivascular cells; white = pulpocytes; red = endothelial 
cells; blue = intranerve cells; yellow = perineural cells. Arrows in-
dicate NG2 immunoreactivity in or around nerves or arteries. As-
terisks indicate space created during histological preparation. 
Scale bars = 50   m. 
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 Fig. 6. Osteo- or chondro-differentiation of DPSCs. DPSCs were 
cultured in osteogenic ( a–i ,  m ), chondrogenic A ( j ,  n ) or B ( l ,  n ) 
media. Two-week-old DPSC monolayers ( a–c ) or 3-week-old mi-
cromass bodies ( g ,  i ) were processed for immunodetection of pro-
collagen I ( a ), osteonectin ( b ,  g ) and osteopontin ( c ). Collagen I 
fibers were detected using Ladewig blue trichrome (blue;  i ). Mul-
tilayered nodules generated after 3–4 weeks of monolayer culture 
were observed by phase contrast microscopy ( d ), and collagen I 
fibers and calcium phosphate (Ca) depositions produced by them 
were detected using Masson’s blue trichrome (blue;  e ) and von 
Kossa (black;  f ) staining, respectively. In 3-week-old micromass 
bodies ( j ,  l ), extracellular matrix-associated acid mucins were de-
tected using Alcian blue staining. Nuclei were visualized with 
DAPI ( a–c ). Sections were counterstained with hematoxylin ( e ,  i , 
 j ), nuclear fast red ( f ,  l ) or light green ( g ). Insets in panels  a–c in-
dicate the corresponding immunodetection in noninduced cells; 
insets in  g and  j demarcate a region displayed at higher magnifi-
cation in  h and  k , respectively. RT-PCR analysis confirmed the 
presence of osteocalcin and bone sialoprotein transcripts in mi-
cromass and monolayer osteodifferentiation cultures ( m , lanes 2 
and 3, respectively) and collagen II and aggrecan transcripts cul-
tured in either chondrogenic A or B media ( n , lanes 2 and 3, re-
spectively) after 6 weeks. For comparison, their transcript level in 
undifferentiated DPSCs is shown ( m ,  n , lane 1). GAPDH was used 
as an internal control ( m ,  n ). C = Negative control, that is without 
cDNA template; M = 100 bp DNA ladder. A representative exper-
iment is shown (n = 3). Scale bars = 50   m. 
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 Differentiation Capacity to a Neural Lineage 
 When grown in the neural expansion medium as a 
uniform cell monolayer ( fig. 8 a), DPSCs could proliferate 
for up to 14 passages without losing the expression of sev-
eral stem cell markers. Under these conditions, they main-
tained the expression of embryonic stem cell markers (for 
example, nanog and Sox-2;  fig. 3 b, lane 1 vs. 3) and up-
regulated the neural/stem cell markers nestin, FORSE-1 
and Bcrp1 ( fig. 3 a, lane 1 vs. 3;  fig. 8 b–d). The expression 
of markers of glial precursors (A2B5) and radial glial cells 
(RC2) was strongly increased ( fig. 8 e, g), whereas NG2, 
Musashi-1 and nucleostemin were almost not affected ( fig.
3 a, lane 1 vs. 3;  fig. 8 f). Astrocytic (glial fibrillary acid-
ic protein), oligodendrocytic (O4) and neuronal (PanNF, 
  -III tubulin) markers were expressed with a heteroge-
neous intensity ( fig. 8 h–k). PanNF- or   -III tubulin-pos-
itive cells were rare under these conditions ( fig. 8 j, k).
 To stimulate neuronal differentiation, cells were fur-
ther cultured either as a monolayer or spheroids. Under 
cell monolayer culture condition in serum-free neuro-
genic medium supplemented with BMP-2 [Kleber et al., 
2005], the cell proliferation stopped ( fig. 8 l) and the num-
 Fig. 7. Endothelial cell differentiation of DPSCs. DPSCs were ini-
tially cultured for 7 days in endothelial medium ( a–k ), and upon 
addition of 10% FCS, for an additional 10 days ( l–p ). Cells were 
plated at a density of 2  ! 10 4 /cm 2 except in  b , where 3  ! 10 4 cells/
cm 2 were used. The expression of several endothelial markers, as 
indicated, was monitored by fluorescence microscopy ( a–h ,  l–p ). 
Insets in panels  a and  c–f indicate corresponding immunodetec-
tion in noninduced cells. As negative controls (Ctrl), a Cy3-con-
jugated anti-mouse IgG, an Alexa Fluor 488-conjugated anti-goat 
or an anti-rabbit IgG secondary Ab was used alone ( i–k , respec-
tively). Nuclei were visualized with DAPI. A representative ex-
periment is shown (n = 3). vWF = von Willebrand factor. Scale 
bars = 50   m. 
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 Fig. 8. Neural differentiation of DPSCs. DPSCs cultured as a cell 
monolayer for 3 wks in neurogenic expansion medium ( a–k ) were 
observed by phase contrast microscopy ( a ), and the expression of 
several antigenic markers, as indicated, was monitored by indirect 
immunofluorescence microscopy ( b–k ). After replating, DPSCs 
were further cultured for seven days in neurogenic expansion me-
dium with ( n ) or without ( l ,  m ,  o ) serum in the presence ( l–o ) of 
BMP-2. Cells were observed by phase contrast microscopy ( l ), and 
the expression of PanNF ( m ,  n ) and   -III tubulin ( o ) was moni-
tored by indirect immunofluorescence microscopy. DPSCs cul-
tured as spheroids in neurogenic expansion medium were ob-
served by phase contrast microscopy ( p ), and the expression of 
neural markers, as indicated, was monitored either by indirect 
immunofluorescence microscopy ( r ,  t ) or peroxidase immuno-
histochemistry ( q ,  s ). Insets in panels  c–e and  g–k indicate cor-
responding immunodetection in noninduced cells. Nuclei were 
 visualized with DAPI ( b–k ,  m–o ,  r ,  t ). Sections were counter-
stained with light green ( q ,  s ). A representative experiment is 
shown (n = 3). Scale bars = 50   m. 
 Characterization of Dental Pulp Stem 
Cells 
Cells Tissues Organs 2011;193:344–365 361
ber of cells expressing PanNF or   -III tubulin was in-
creased significantly ( fig. 8 m, o). This differentiation pro-
cess was inhibited when the serum (1%) was added 
( fig.  8 n; data not shown). In neurospheres cultured in 
neurogenic expansion medium, cells located at the pe-
riphery expressed markers (nestin, A2B5,   -III tubulin 
and O4) associated with both immature and differenti-
ated neural cells, whereas those found in the center were 
negative ( fig.  8 q–t). Taken together, these data demon-
strate that DPSCs have the capacity to generate various 
types of neural cells.
 Discussion 
 In this study, we carried out extensive antigenic char-
acterization of DPSCs isolated and expanded in media 
containing low amounts of serum in the presence of EGF 
and PDGF-BB. Moreover, we demonstrated their multi-
potential differentiation capacity. Because dental pulp is 
easily removable from teeth recovered by standard dental 
procedures in childhood or adulthood, and due to the 
excellent ex vivo proliferation capacity of DPSCs 
[Suchanek et al., 2007], pulp might become a valuable au-
tologous source of somatic stem cells.
 The isolation and ex vivo expansion of DPSCs in basic 
expansion medium containing growth factors (EGF and 
PDGF-BB), which were reported to have mitogenic effects 
on both bone marrow stromal cells [Gronthos and Sim-
mons, 1995] and multipotent adult progenitor cells [Reyes 
et al., 2002], require a minimum amount of serum (2%) 
to ensure their adhesion to a plastic substrate after pulp 
dissociation and to maintain an optimal long-term pro-
liferation activity. However, we could observe that the 
number of adhered cells following isolation was lower 
than that recovered in media containing high amounts of 
serum (10–20%, 2- to 3-fold; unpublished observations) 
[Suchanek et al., 2007], suggesting the media containing 
low amounts of serum might exert selective pressure sup-
porting the adhesion and growth of a different and/or 
specific DPSC subpopulation displaying a more imma-
ture phenotype (see below). In a previous study, we dem-
onstrated that under these culture conditions, DPSCs 
were able to expand for over 60 population doublings 
without any sign of spontaneous malignant transforma-
tion [Suchanek et al., 2007], though such transformation 
has been reported in long-term cultures of adult mesen-
chymal adipose or bone marrow stem cells [Rubio et al., 
2005; Wang et al., 2005; Miura et al., 2006; Zhou et al., 
2006; Rosland et al., 2009]. Coincidentally, in all of these 
reported cases, media containing high amounts of serum 
were used, which might be responsible for such cellular 
transformation. In agreement with this assumption, it 
was reported that the gene expression signature induced 
in fibroblasts upon exposure to 10% serum was similar to 
that found in cancer cells [Chang et al., 2004]. Thus, from 
a clinical perspective, the serum level tested here repre-
sents an interesting cellular system for the ex vivo expan-
sion of DPSCs having a similar, but not identical, anti-
genic profile and differentiation properties to those gen-
erated in media containing high amounts of serum 
[Gronthos et al., 2000; Kerkis et al., 2006; Yalvac et al., 
2010].
 Our data showed that the expression profile of several 
stem cell-associated markers (nestin, Musashi-1, nanog, 
Sox-2) in DPSCs expanded in media containing low 
amounts of serum in the presence of EGF and PDGF-BB 
is highly comparable to those cultured under a condition 
of high amounts of serum with two notable exceptions, 
  -SMA and CD146, which are poorly expressed under 
the former culture conditions ( fig. 2 ,  3 ,  4 a, b). These pro-
teins deserve particular attention, given that they have 
been reported to be expressed by certain dental pulp-de-
rived stem cells (also cultured in media containing high 
amounts of serum) having a clonogenic capacity [Shi and 
Gronthos, 2003]. Even more strikingly, CD146 may be 
considered as a marker of certain endothelial, pericytic, 
smooth muscle cells, stromal and perivascular mesen-
chymal stem cells [Bardin et al., 1996; Shi and Gronthos, 
2003; Baksh et al., 2007; Sacchetti et al., 2007; Sorrentino 
et al., 2008] as well as cancer cells [Lehmann et al., 1989; 
Shih et al., 1996; Wu et al., 2001; Aldovini et al., 2006; 
Zabouo et al., 2009]. The capacity of DPSCs cultured in 
media containing low amounts of serum to differentiate 
into various lineages indicates that CD146 (as well as   -
SMA) is dispensable for this capacity and indirectly sug-
gests that distinct pools of DPSCs may co-exist in vivo. 
The limited number of CD146 (  -SMA)-positive cells ob-
tained here may be explained by the lack of either their 
initial adhesion or proliferation. Indeed, we could recov-
er more than 65% CD146-positive cells using a medium 
containing high amounts of serum (J.K., unpublished 
data), which is in line with the higher number of adherent 
cells initially obtained (see above). Moreover, the shift 
from low to high serum-containing media did not fully 
restore the expression of CD146 and   -SMA, suggesting 
on the one hand that we are dealing with distinct cell 
populations [Verbeek et al., 1994]. On the other hand, it 
could not be formally excluded that using the combina-
tion of the growth factors PDGF-BB and EGF to stimulate 
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the cell proliferation may also selectively inhibit their ex-
pression [Corjay et al., 1989]. 
 Based on the expression of CD146,   -SMA, 3G5 and 
STRO-1, it was proposed that DPSCs originate from the 
perivascular niche [Shi and Gronthos, 2003]. The differ-
ential expression of the first two markers observed here 
has prompted us to re-examine the possible origin of
DPSCs, also considering the expression of neural progen-
itor markers such as Musashi-1, nestin and NG2. Our im-
munohistochemical analysis of immature dental pulp in-
dicated 4 alternative, but not exclusive, DPSC sources 
( fig. 5 ). In addition to the perivascular niche, where cells 
with the molecular signature   -SMA, CD146, Musashi-1, 
nestin and NG2 are located, DPSCs may originate from 
intranerve cells (  -SMA, Musashi-1, nestin and NG2), 
pulpocytes found in connective tissues (  -SMA, Mu-
sashi-1, nestin and NG2) or perineural cells surrounding 
nerve fibers (Musashi-1, nestin and NG2). Thus, consid-
ering the absence of CD146 (and eventually   -SMA), al-
ternative location(s) may host distinct DPSC subpopula-
tions. Obviously, further investigations are needed to dis-
sect the dental stem cell niche in more detail. 
 It was previously suggested that dental pulp originates 
from neural crest cells that give rise during development 
to dental pulp with odontoblasts and pulpocytes, cement-
oblasts and periodontal cells of the tooth and to multiple 
other tissues including facial bone and cartilage, vascular 
smooth muscle and peripheral nervous system [Thesleff 
and Aberg, 1999; Chai et al., 2000; Graham et al., 2004; 
Miletich and Sharpe, 2004]. It is highly probable that den-
tal pulp contains neural crest-derived dormant stem cells 
that can be isolated and ex vivo expanded while main-
taining their neural crest multipotential properties. In 
agreement with this presumption, we demonstrated that 
DPSCs treated with appropriate cues could differentiate 
into osteoblasts, chondroblasts, smooth muscle, endothe-
lial and neural cells, as previously reported for those de-
rived under high serum-containing conditions [Gron-
thos et al., 2000; Alliot-Licht et al., 2001; Miura et al., 
2003; Kerkis et al., 2006; Arthur et al., 2008; Stevens et al., 
2008; Nakashima et al., 2009; Yalvac et al., 2010]. In par-
ticular, endothelial cells are quite rare representatives of 
neural crest derivates. Only cells from the caudal part of 
the cranial (cardiac) neural crest are known to contribute 
to the formation of the endothelium and smooth muscle 
layer of aortic arch arteries [Waldo et al., 1998]. Neverthe-
less, we were able to induce the expression of certain en-
dothelial markers, which is in line with recent studies re-
porting the angiogenic potential of DPSCs [Iohara et al., 
2008; Marchionni et al., 2009; Nakashima et al., 2009; 
Yalvac et al., 2010]. The expression of VEGFR2 (KDR, 
Flk-1) might explain the predisposition of these cells to 
respond to VEGF in differentiation conditions. Certain 
in vitro analyses have shown that a common VEGFR2-
positive vascular progenitor exists that is derived from 
embryonic stem cells and has the ability to differentiate 
into endothelial cells in the presence of VEGF and into 
vascular smooth muscle cells in the presence of PDGF-BB 
[Yamashita et al., 2000; Carmeliet, 2004]. This is in agree-
ment with our data showing that the stimulation of
DPSCs with appropriate growth factors gave rise to cells 
with a phenotype of endothelial cells or   -SMA-positive 
smooth muscle cells.
 Finally, we showed that DPSCs can be committed to 
the neural lineage and further propagated in the neuro-
genic expansion medium while preserving or upregulat-
ing the expression of neural markers including Sox-2 
[Zappone et al., 2000; Ellis et al., 2004], nucleostemin 
[Tsai and McKay, 2002], Musashi-1 [Kaneko et al., 2000], 
nestin [Lendahl et al., 1990] and LeX/FORSE-1/SSEA-1 
[Allendoerfer et al., 1995; Capela and Temple, 2006; 
Pruszak et al., 2007]. This molecular profile, together 
with the upregulation of Bcrp1, is characteristic not only 
of neural stem cells, but also of neural crest stem cells iso-
lated from different sources in mice [Tomita et al., 2005; 
Yoshida et al., 2006] or humans [Thomas et al., 2008]. 
Furthermore, we observed that DPSCs could be induced 
under appropriate culture conditions to a neuronal phe-
notype similar to those derived from high serum-content 
media conditions in which they were found to differenti-
ate to functionally active neurons [Arthur et al., 2008]. 
Other studies have documented that DPSCs secrete many 
neurotrophic growth factors, such as BDNF, CNTF, FGF, 
GDNF, NGF and VEGF, which were found to promote 
neuronal rescue and survival, neurite outgrowth and 
guidance in vitro and in vivo [Nosrat et al., 2001; Nosrat 
et al., 2004; Arthur et al., 2009] and to stimulate neuro-
genesis after transplantation in the hippocampus [Huang 
et al., 2008]. These new facets of DPSCs present the excit-
ing possibility of using this primary cell culture system 
as a starting point in further studies aimed at the deriva-
tion of neuronal cells that could be employed in therapies 
of neurodegenerative disorders. However, it is important 
to mention that, in contrast to stem cells derived from the 
central nervous system, the efficient growth of DPSCs on 
three-dimensional structures, such as spheroids, was 
achieved only in the presence of serum. Furthermore, on 
spheroids, only peripheral cells maintained the expres-
sion of both immature and mature neural markers, 
whereas those located centrally, which were expected to 
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differentiate into glial and neuronal cells as in conven-
tional neurospheres [Mokry et al., 2008], lacked them. 
Thus, the behavior of DPSCs on three-dimensional struc-
tures seems to somehow be different from primitive cells 
derived from the central nervous system.
 In conclusion, our data indicate that isolated DPSCs 
cultured in media containing low amounts of serum in 
the presence of EGF and PDGF-BB simultaneously share 
the antigenic profile of mesenchymal and neural stem 
cells and, furthermore, express certain markers of em-
bryonic stem cells. Additionally, we showed that these 
cells have the capacity to generate multiple lineages. In 
particular, the possibility of expanding DPSCs commit-
ted to a neural lineage and specifically differentiating 
them further represents a new direction in the field of tis-
sue engineering and therapy of neurodegenerative disor-
ders based on utilizing non-central nervous system cells. 
Further studies focusing on the directed differentiation 
of DPSCs into specific neuronal cells, their possible tro-
phic support of degenerating neurons and their general 
neurosecretoric activity might result in new advances in 
treatment of, for example, Parkinson’s disease. Moreover, 
the differential expression of CD146 and   -SMA ob-
served between cells isolated and expanded in low versus 
high serum-content media suggest that distinct multipo-
tent stem cells might co-exist within the dental pulp. It 
will be of interest to determine the transcriptome and/or 
proteome of both the positive versus negative subpopula-
tions of CD146 (or   -SMA). Collectively, the ready avail-
ability of these cells, an easy isolation process and the 
unique culture characteristics of this innovative culture 
system make DPSCs a possible reliable source of somatic 
stem cells that might be considered for use in tissue engi-
neering and cell-based replacement.
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